BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31714431)

  • 21. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.
    Mao L; Li J; Chen WX; Cai YQ; Yu DD; Zhong SL; Zhao JH; Zhou JW; Tang JH
    Tumour Biol; 2016 Apr; 37(4):5247-56. PubMed ID: 26555545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Religious Involvement on HIV Management Outcomes Among HIV-Positive Adults in Central North Carolina.
    Yates T; Yates S; Rushing J; Schafer KR
    South Med J; 2018 Oct; 111(10):612-618. PubMed ID: 30285268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project.
    Been SK; van de Vijver DA; Nieuwkerk PT; Brito I; Stutterheim SE; Bos AE; Wolfers ME; Pogány K; Verbon A
    PLoS One; 2016; 11(10):e0162800. PubMed ID: 27706251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heroin Abuse and/or HIV Infection Dysregulate Plasma Exosomal miRNAs.
    Wang X; Sun L; Zhou Y; Su QJ; Li JL; Ye L; Liu MQ; Zhou W; Ho WZ
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):400-408. PubMed ID: 31828734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
    Grierson J; Koelmeyer RL; Smith A; Pitts M
    HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab May Cause Increased Hepatitis C Virus Viremia in Rheumatoid Arthritis Patients Through Declining Exosomal MicroRNA-155.
    Liao TL; Hsieh SL; Chen YM; Chen HH; Liu HJ; Lee HC; Chen DY
    Arthritis Rheumatol; 2018 Aug; 70(8):1209-1219. PubMed ID: 29575671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome.
    Gelpi M; Mikaeloff F; Knudsen AD; Benfeitas R; Krishnan S; Svenssson Akusjärvi S; Høgh J; Murray DD; Ullum H; Neogi U; Nielsen SD
    Aging (Albany NY); 2021 Oct; 13(19):22732-22751. PubMed ID: 34635603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.
    Nance RM; Delaney JAC; Simoni JM; Wilson IB; Mayer KH; Whitney BM; Aunon FM; Safren SA; Mugavero MJ; Mathews WC; Christopoulos KA; Eron JJ; Napravnik S; Moore RD; Rodriguez B; Lau B; Fredericksen RJ; Saag MS; Kitahata MM; Crane HM
    Ann Intern Med; 2018 Sep; 169(6):376-384. PubMed ID: 30140916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.
    Sarfo FS; Nichols M; Agyei B; Singh A; Ennin E; Nyantakyi AD; Asibey SO; Tagge R; Gebregziabher M; Jenkins C; Ovbiagele B
    J Neurol Sci; 2019 Feb; 397():103-111. PubMed ID: 30599299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging.
    Sil S; Niu F; Chivero ET; Singh S; Periyasamy P; Buch S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
    Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
    J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients.
    Ceccarelli G; Fratino M; Selvaggi C; Giustini N; Serafino S; Schietroma I; Corano Scheri G; Pavone P; Passavanti G; Alunni Fegatelli D; Mezzaroma I; Antonelli G; Vullo V; Scagnolari C; d'Ettorre G
    Brain Behav; 2017 Aug; 7(8):e00756. PubMed ID: 28828217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.
    Tozzi V; Balestra P; Salvatori MF; Vlassi C; Liuzzi G; Giancola ML; Giulianelli M; Narciso P; Antinori A
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):56-63. PubMed ID: 19731418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression profiling of human milk derived exosomal microRNAs and their targets in HIV-1 infected mothers.
    Zahoor MA; Yao XD; Henrick BM; Verschoor CP; Abimiku A; Osawe S; Rosenthal KL
    Sci Rep; 2020 Jul; 10(1):12931. PubMed ID: 32737406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum exosomal microRNAs as potent circulating biomarkers for melanoma.
    Tengda L; Shuping L; Mingli G; Jie G; Yun L; Weiwei Z; Anmei D
    Melanoma Res; 2018 Aug; 28(4):295-303. PubMed ID: 29750752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression profiles of bovine milk exosomes in response to Staphylococcus aureus infection.
    Sun J; Aswath K; Schroeder SG; Lippolis JD; Reinhardt TA; Sonstegard TS
    BMC Genomics; 2015 Oct; 16():806. PubMed ID: 26475455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
    Duran-Castells C; Llano A; Kawana-Tachikawa A; Prats A; Martinez-Zalacain I; Kobayashi-Ishihara M; Oriol-Tordera B; Peña R; Gálvez C; Silva-Arrieta S; Clotet B; Riveira-Muñoz E; Ballana E; Prado JG; Martinez-Picado J; Sanchez J; Mothe B; Hartigan-O'Connor D; Wyss-Coray T; Meyerhans A; Gisslén M; Price RW; Soriano-Mas C; Muñoz-Moreno JA; Brander C; Ruiz-Riol M
    J Virol; 2023 Feb; 97(2):e0165522. PubMed ID: 36719240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Challenges of HIV-1 Infection: How HIV-1 Attacks and Resides in the Central Nervous System.
    Rojas-Celis V; Valiente-Echeverría F; Soto-Rifo R; Toro-Ascuy D
    Cells; 2019 Oct; 8(10):. PubMed ID: 31614895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study.
    Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S;
    PLoS One; 2015; 10(10):e0139981. PubMed ID: 26465293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.
    Vecchio AC; Marra CM; Schouten J; Jiang H; Kumwenda J; Supparatpinyo K; Hakim J; Sacktor N; Campbell TB; Tripathy S; Kumarasamy N; La Rosa A; Santos B; Silva MT; Kanyama C; Firnhaber C; Hosseinipour MC; Mngqibisa R; Hall C; Cinque P; Robertson K
    Clin Infect Dis; 2020 Jun; 71(1):158-165. PubMed ID: 31630166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.